Are CB1 antagonists the answer to reducing cognitive deficits in schizophrenia?

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/201031/12/2010

Funding

  • NARSAD National Alliance for Research on Schizophrenia and Depression: £14,181.50